Neurotransmitter changes in cerebrospinal fluid in the Spanish toxic oil syndrome: human clinical findings and experimental results in mice

Neurosci Lett. 1986 Jun 18;67(2):135-40. doi: 10.1016/0304-3940(86)90386-1.

Abstract

Patients with Spanish Toxic Oil Syndrome (TOS) complaining of neuromuscular symptoms had increased levels of homovanillic acid and 5-hydroxyindoleacetic acid (5-HIAA) in cerebrospinal fluid. Severity of pain and muscle cramps correlated with the magnitude of increment in levels of monoamine metabolites. Mice treated with oleyl anilide, a putative toxic compound found in some stocks of the toxic rapeseed oil, did not present clinical or anatomical findings compatible with TOS. However, biochemical studies in these mice revealed a depletion of serotonin and an elevation of 5-HIAA levels. Our findings suggest that the unidentified toxic agent of the TOS and oleyl anilide induce pharmacological changes in monoamine neurons of the brain.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Anilides / toxicity*
  • Animals
  • Brain Chemistry
  • Brassica*
  • Catecholamines / analysis
  • Disease Models, Animal
  • Foodborne Diseases / cerebrospinal fluid*
  • Homovanillic Acid / cerebrospinal fluid*
  • Humans
  • Hydroxyindoleacetic Acid / cerebrospinal fluid*
  • Mice
  • Oils / poisoning*
  • Oleic Acids / toxicity*
  • Pain / cerebrospinal fluid

Substances

  • Anilides
  • Catecholamines
  • Oils
  • Oleic Acids
  • Hydroxyindoleacetic Acid
  • oleoylanilide
  • Homovanillic Acid